TruWealth Advisors LLC Trims Position in The Allstate Co. (NYSE:ALL)

TruWealth Advisors LLC trimmed its position in The Allstate Co. (NYSE:ALL) by 13.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,320 shares of the insurance provider’s stock after selling 205 shares during the quarter. TruWealth Advisors LLC’s holdings in Allstate were worth $254,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of ALL. Ameritas Advisory Services LLC lifted its stake in Allstate by 117.3% in the 4th quarter. Ameritas Advisory Services LLC now owns 4,896 shares of the insurance provider’s stock worth $944,000 after purchasing an additional 2,643 shares in the last quarter. Premier Path Wealth Partners LLC increased its holdings in shares of Allstate by 4.7% in the fourth quarter. Premier Path Wealth Partners LLC now owns 2,480 shares of the insurance provider’s stock worth $478,000 after purchasing an additional 112 shares during the period. Merit Financial Group LLC raised its position in shares of Allstate by 78.9% in the fourth quarter. Merit Financial Group LLC now owns 3,909 shares of the insurance provider’s stock worth $754,000 after buying an additional 1,724 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its stake in Allstate by 30.5% during the fourth quarter. Wealthcare Advisory Partners LLC now owns 1,456 shares of the insurance provider’s stock valued at $281,000 after buying an additional 340 shares during the period. Finally, Avanza Fonder AB purchased a new position in Allstate during the fourth quarter worth about $4,299,000. 76.47% of the stock is currently owned by institutional investors.

Allstate Price Performance

ALL opened at $188.85 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The Allstate Co. has a 1 year low of $150.17 and a 1 year high of $209.88. The stock’s 50 day simple moving average is $195.73 and its 200 day simple moving average is $186.32. The firm has a market cap of $50.01 billion, a price-to-earnings ratio of 12.23, a PEG ratio of 1.35 and a beta of 0.52.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter last year, the business earned $0.81 earnings per share. The business’s revenue was up 14.7% on a year-over-year basis. As a group, analysts predict that The Allstate Co. will post 16.45 earnings per share for the current year.

Allstate Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th were paid a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 1.95%. The ex-dividend date was Friday, November 29th. Allstate’s dividend payout ratio (DPR) is 23.83%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Jefferies Financial Group lifted their price target on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research report on Friday, November 8th. UBS Group boosted their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. The Goldman Sachs Group raised their price objective on shares of Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a research report on Friday, November 15th. BMO Capital Markets upped their target price on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, Barclays lowered their price target on Allstate from $187.00 to $183.00 and set an “underweight” rating on the stock in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $218.13.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.